BioNTech BNTX
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 44th percentile, 5-year average -5.2x
Near the bottom of its 5-year range · 13th percentile, 5-year average 1.6x
#1673 of 5338 stocks by PB (1 = cheapest)
Above its usual level · 74th percentile, 5-year average 5.1x
#4384 of 5161 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.03 | – | 1.61 | 13% (cheaper than usual) | #1673 of 5338 (1 = cheapest) |
| PE | -12.55 | -16.73 | -5.21 | 44% (cheaper than usual) | – |
| PS | 7.56 | 12.33 | 5.10 | 74% (pricier than usual) | #4384 of 5161 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on BNTX.
Sign in to join the discussion.